GlassScriptPhysician profile
Sara B Gibson
NPI 1336307446
$2,584.80
in general payments reported to CMS, 2019-2025
24 companies · $1,272 in 2025
The $1,272 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $84.05 · 2022: $561 · 2023: $193 · 2024: $120 · 2025: $1,272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Food and Beverage: $499 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Food and Beverage | $499.06 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,000.00 | 2025 | |
| Abbvie INC. | $314.15 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $145.86 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $140.36 | 2019-2025 | |
| Astellas Pharma US INC | $134.57 | 2025 | Veozah |
| Evofem Biosciences, INC. | $108.38 | 2022-2025 | Phexxi, Solosec, Phexx |
| Avion Pharmaceuticals | $90.73 | 2019-2023 | Balcoltra |
| Sumitomo Pharma America, INC. | $86.84 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $73.31 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Aspira Women'S Health INC | $63.51 | 2022-2024 | Ova1 |
| Organon LLC | $55.86 | 2022-2024 | |
| Pfizer INC. | $50.76 | 2022-2024 | |
| Lupin INC. | $45.48 | 2019 | |
| Myovant Sciences INC. | $43.20 | 2022 | |
| Therapeuticsmd, INC. | $35.88 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $33.44 | 2019-2025 | Paragard T 380a |
| Allergan, INC. | $30.30 | 2019 | |
| Mission Pharmacal Company | $29.46 | 2019 | |
| Smith+Nephew, INC. | $21.82 | 2022 | |
| Mylan Pharmaceuticals INC. | $20.65 | 2022 | |
| Roche Diagnostics Corporation | $16.81 | 2019 | |
| Meditrina | $16.02 | 2022 | |
| Integra Lifesciences Corporation | $15.92 | 2022 | |
| Minerva Surgical, INC | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Gibson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.